Development of the China's list of ambulatory care sensitive conditions (ACSCs): a study protocol.

Autor: Wang J; HEOA Group, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China., Xu DR; School of Health Management, Southern Medical University, Guangzhou, China., Zhang Y; School of Medicine and Health Management, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Fu H; Department of Health Policy and Management, School of Public Health, Peking University Health Science Center, Beijing, China., Wang S; Vanke School of Public Health, Tsinghua University, Beijing, China., Ju K; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia., Chen C; School of Health Management, Fujian Medical University, Fujian, China., Yang L; School of Public Health, Chengdu University of Traditional Chinese Medicine, Chengdu, China., Jian W; Department of Health Policy and Management, School of Public Health, Peking University Health Science Center, Beijing, China., Chen L; Department of Neurology, West China Hospital, Sichuan University, Chengdu, China., Liao X; General Practice Ward/International Medical Center Ward, General Practice Medical Center, West China Hospital, Sichuan University, Chengdu, China., Xiao Y; China National Health Development Research Center, Beijing, China., Wu R; Center for Health Statistics and Information, National Health Commission, Beijing, China., Jakovljevic M; Institute of Advanced Manufacturing Technologies, Peter the Great St. Petersburg Polytechnic University, St. Petersburg, Russia.; Institute of Comparative Economic Studies, Faculty of Economics, Hosei University, Tokyo, Japan.; Department of Global Health Economics and Policy, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia., Chen Y; Research Unit of Evidence-Based Evaluation and Guidelines, Chinese Academy of Medical Sciences (2021RU017), School of Basic Medical Sciences, Lanzhou University, Lanzhou, China. chenyaolong@lzu.edu.cn.; World Health Organization Collaborating Center for Guideline Implementation and Knowledge Translation, Lanzhou University, Lanzhou, China. chenyaolong@lzu.edu.cn., Pan J; HEOA Group, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China. panjie.jay@scu.edu.cn.; Institute for Healthy Cities and West China Research Center for Rural Health Development, Sichuan University, Chengdu, China. panjie.jay@scu.edu.cn.
Jazyk: angličtina
Zdroj: Global health research and policy [Glob Health Res Policy] 2024 Mar 19; Vol. 9 (1), pp. 11. Date of Electronic Publication: 2024 Mar 19.
DOI: 10.1186/s41256-024-00350-5
Abstrakt: Background: The hospitalization rate of ambulatory care sensitive conditions (ACSCs) has been recognized as an essential indicator reflective of the overall performance of healthcare system. At present, ACSCs has been widely used in practice and research to evaluate health service quality and efficiency worldwide. The definition of ACSCs varies across countries due to different challenges posed on healthcare systems. However, China does not have its own list of ACSCs. The study aims to develop a list to meet health system monitoring, reporting and evaluation needs in China.
Methods: To develop the list, we will combine the best methodological evidence available with real-world evidence, adopt a systematic and rigorous process and absorb multidisciplinary expertise. Specific steps include: (1) establishment of working groups; (2) generations of the initial list (review of already published lists, semi-structured interviews, calculations of hospitalization rate); (3) optimization of the list (evidence evaluation, Delphi consensus survey); and (4) approval of a final version of China's ACSCs list. Within each step of the process, we will calculate frequencies and proportions, use descriptive analysis to summarize and draw conclusions, discuss the results, draft a report, and refine the list.
Discussion: Once completed, China's list of ACSCs can be used to comprehensively evaluate the current situation and performance of health services, identify flaws and deficiencies embedded in the healthcare system to provide evidence-based implications to inform decision-makings towards the optimization of China's healthcare system. The experiences might be broadly applicable and serve the purpose of being a prime example for nations with similar conditions.
(© 2024. The Author(s).)
Databáze: MEDLINE